Jiangsu, China

Heng Ge

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heng Ge. Retrieved from https://idiyas.com/inventor/heng-ge-0lof1rnc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Heng Ge: A Pioneer in Pharmaceutical Development

Introduction: Heng Ge, an accomplished inventor based in Jiangsu, China, has made significant contributions to the field of pharmaceuticals. With a focus on innovative compounds, he has successfully secured a patent that showcases his expertise and dedication to advancing medical treatments.

Latest Patents: Heng Ge is the inventor of a patent titled "Naphthyridinone derivatives for the treatment of a disease or disorder." This invention details a compound represented by a specific formula, including a pharmaceutically acceptable salt. The patent outlines various compositions and methods for using these new compounds, demonstrating their potential in treating various diseases and disorders.

Career Highlights: Heng Ge works with Novartis AG, a renowned global healthcare company dedicated to the development and delivery of innovative medicines. His role within the organization highlights his commitment to enhancing healthcare through scientific research and innovation.

Collaborations: Throughout his career, Heng Ge has collaborated with notable colleagues, including Atwood Kim Cheung and Donglei Liu. Their combined expertise and teamwork have contributed to advancing research and developing impactful pharmaceutical solutions.

Conclusion: Heng Ge's work in pharmaceutical innovation underscores the importance of dedicated inventors in the fight against diseases. His patent for naphthyridinone derivatives not only represents a significant milestone in his career but also offers hope for new treatment options in the healthcare industry. As he continues to collaborate and innovate, the future looks promising for Heng Ge and the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…